Your Article Summary
GSK Signs $120M Deal to Market DMab Overseas
PharmExec, 07/31/09
In an effort to boost its sales force without hiring more sales reps, Amgen announced on Tuesday that it has signed a deal with GlaxoSmithKline to co–market its osteoporosis treatment denosumab–currently pending FDA approval.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Bristol Myers-Squibb Company, 12/07/09
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Article Search
Sponsor


See Latest Articles


